Transforming growth factor-β1 in chronic hepatitis C

Journal of Viral Hepatitis

Volumn 4, Issue 1, 1997, Pages 29-35

  Nelson, D R ^a   Gonzalez Peralta, R P ^a   Qian, K ^a   Xu, Y ^a   Marousis, C G ^a   Davis, G L ^a   Lau, J Y N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Fibrosis; HCV; TGF 1

Indexed keywords

INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC DISEASE; FEMALE; HEPATITIS C; HUMAN; LIVER; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HEPATITIS C; HUMANS; INTERLEUKIN-4; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030638521     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00124.x     Document Type: Article

References (24)

1. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
2. Lau JYN. Hepatitis C virus: from epidemiology and molecular virology to immunology. Hepatology 1994; 20: 760-762.
3. Border WA, Noble NA. Transforming growth factor in tissue fibrosis. N Eugl J Med 1994; 331: 1286-1292.
4. Border WA, Ruoslahti E. Transforming growth factor in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1-7.
5. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 1995; 108: 145-156.
6. Bachem M, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. J Clin Invest 1992; 89: 19-27.
7. 1 with hepatic fibrosis. J Cell Biol 1989; 108: 2477-2482.
8. 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest 1990; 63: 171-180,
9. 1 and α in chronic liver disease: effects of interferon alpha therapy. N Engl J Med 1991; 324: 933-940.
10. Nakamura T, Tomita Y, Hirai R, Yamaoki K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985; 133: 1042-1050.
11. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic viral hepatitis, grading, and staging. Hepatology 1994; 19: 1513-1520.
12. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
13. Davis GL, Lau JYN, Urdea MS et al. Quantitative detection of hepatitis C virus (HCV) RNA by a solid phase branched chain DNA amplification method: definition of optimal condition for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337-1341.
14. Lau JYN, Davis GL, Brunson ME et al. Hepatitis C virus infection in renal transplant recipients. Hepatology 1993; 18: 1027-1031.
15. Lau JYN, Simmonds P, Urdea MS. Implications of variations of 'conserved' regions of hepatitis C virus genome. Lancet 1995; 346: 425-426.
16. Davidson F, Simmonds P, Ferguson JC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 1197-1204.
17. Lau JYN, Mizokami M, Kolberg JA et al. Application of six hepatitis C virus genotyping systems to sera from patients with chronic hepatitis C in the United States. J Infect Dis 1995; 171: 281-289.
18. Simmonds P, Alberti A, Bonino F et al. A proposed nomenclature system of genotypes for hepatitis C virus. Hepatology 1994; 19: 1321-1324.
19. Mire-Sluis AR, Page L, Wadhwa M, Thorpe R. Transforming growth factor-beta 1 blocks interleukin 4 induced cell proliferation by inhibiting a protein tyrosine phosphatase essential for signal transduction. Cytokine 1994; 6: 389-398.
20. Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037-1050.
21. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986; 137: 3855-3860.
22. Rook AH, Kehrl JH, Wakefield LM et al. Effects of transforming growth factor β on the function of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986; 136: 3916-3920.
23. Gabrielian K, Osusky R, Sippy BD, Ryan SJ, Hinton DR. Effect of TGF-beta on interferon-gamma-induced HLA-DR expression in human retinal pigment epithelial cells, Invest Opthalmol Vis Sci 1994; 35: 4253-4259.
24. 1 to preferentially inhibit the induction of cytotoxicity in human T cells is determined by the nature of the activating signals. Anticancer Res 1994; 14: 1595-1598.